Driving Efficiency & Unlocking Scalability for PRAME Cell Therapy Manufacturing

• Anzu-cel is TCR T-cell therapy directed against PRAME, a target expressed in more than 50 cancers
• Scaling out efficiently: horizontal expansion to increase speed and throughput
• Preparing for commercial manufacturing through operational excellence

Speakers:

Ali Mohamed

Senior Vice President, CMC

Immatics